- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02309203
Canadian Study of the MicroVention Flow Re-Direction (FRED) Endoluminal Device Stent System in the Treatment of Intracranial Aneurysms (CanFRED)
July 27, 2015 updated by: Jean Raymond, Centre hospitalier de l'Université de Montréal (CHUM)
Canadian Study of the MicroVention Flow Re-Direction (FRED) Endoluminal Device Stent System in the Treatment of Intracranial Aneurysms - The CanFRED Trial
The study objective is to evaluate the safety and effectiveness of the MicroVention FRED System when used in the treatment of wide-necked intracranial aneurysms.
Study Overview
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject whose age is ≥ 18 years;
- Subject has a single target aneurysm located in the following zones:
- Zone 1 - Petrous through cavernous of the ICA
- Zone 2 - Ophthalmic segment of the ICA
- Zone 3-Posterior Circulation, basilar artery (not including the basilar bifurcation), vertebral artery
- Subjects with a single target intracranial aneurysm located along the internal carotid artery, or the vertebral or basilar artery for whom existing endovascular options (coiling, stent-assisted-coiling) could be ineffective or because aneurysm is predisposed to recurrence due to having any of the following characteristics:
- Aneurysms with a neck > 4mm, dome to neck ratio ≤2 or no discernible neck
- Fusiform aneurysms of any size requiring treatment;
- The parent artery must have a diameter of 2.5 - 5.0mm distal/proximal to the target intracranial aneurysm (IA);
- Subject fulfills study requirements, and the subject or his/her legally authorized representative provides a signed informed consent form;
- Negative pregnancy test in a female subject who has had menses in the last 24 months;
- Subject is willing to return for the 1-month and 6-month follow-up evaluations
Exclusion Criteria:
- Subject who is pregnant or breastfeeding; Subject who suffers from a subarachnoid hemorrhage in the last 60 days;
- Subject who suffers from any intracranial hemorrhage in the last 30 days;
- Subject currently undergoing radiation therapy for carcinoma or sarcoma of the head or neck region;
- Subject with stenosis of the parent artery (>50%) proximal to the target aneurysm;
- Subject with known platelet dysfunction or a contraindication to or inability to tolerate anticoagulants/antiplatelet agents;
- Subject with contraindications or severe allergies to anticoagulants or antiplatelet medications (aspirin, heparin, ticlopidine, clopidogrel, prasugrel or ticagrelor);
- Subject with known hypersensitivity to metal, such as nickel-titanium and metal jewelry
- Subject with documented contrast allergy, or other condition, that prohibits imaging.
- Evidence of active bacterial infection at the time of treatment;
- Subject who has had a previous intracranial stenting procedure associated with the target aneurysm;
- Subject with life-threatening diseases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Flow Re-Direction Endoluminal Device
Flow Re-Direction Endoluminal Device (FRED Device)
|
Flow Re-Direction Endoluminal Device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
death or major stroke
Time Frame: within 30 days post procedure
|
A major stroke is defined as a new neurological event that persists for > 24 hours and results in a mRS >2.
A minor stroke is defined as a new neurological event that persists for > 24 hours.
|
within 30 days post procedure
|
neurological death or major ipsilateral stroke, measured by mRS.
Time Frame: within 6 months post procedure
|
within 6 months post procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of FRED System and procedure related Serious Adverse Events;
Time Frame: 1 year
|
1 year
|
|
Incidence of successful delivery of the FRED System implant;
Time Frame: 24 hours
|
24 hours
|
|
Incidence of migration of the FRED System implant
Time Frame: 6 months
|
6 months
|
|
Unplanned alternative treatment on the target IA (Defined as re-treatment of the target aneurysm due to worsening of the clinical condition of the subject)
Time Frame: Within 6 months
|
Defined as re-treatment of the target aneurysm due to worsening of the clinical condition of the subject
|
Within 6 months
|
Change in clinical and functional outcomes (as measured by an increase in the modified Rankin Scale compared to baseline)
Time Frame: 6 months
|
as measured by an increase in the modified Rankin Scale compared to baseline
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Primary Completion (Anticipated)
February 1, 2017
Study Completion (Anticipated)
September 1, 2017
Study Registration Dates
First Submitted
December 3, 2014
First Submitted That Met QC Criteria
December 4, 2014
First Posted (Estimate)
December 5, 2014
Study Record Updates
Last Update Posted (Estimate)
July 28, 2015
Last Update Submitted That Met QC Criteria
July 27, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CE 14.295
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intracranial Aneurysms
-
Microvention-Terumo, Inc.UnknownIntracranial Aneurysms | Wide Neck Bifurcation Intracranial AneurysmsUnited States, Denmark, Canada, Hungary, Germany, Turkey
-
Penumbra Inc.CompletedIntracranial Aneurysms | Peripheral AneurysmsUnited States
-
Icahn School of Medicine at Mount SinaiKaneka CorporationRecruitingIntracranial Aneurysms | Wide Neck Intracranial AneurysmsUnited States
-
Zhujiang HospitalSecond Affiliated Hospital, School of Medicine, Zhejiang University; Xuanwu... and other collaboratorsUnknownUnruptured Intracranial Aneurysms | Ruptured Intracranial Aneurysms | Stent-Assisted Coiling | Non-Stent-Assisted Coiling | Craniotomy ClippingChina
-
Microvention-Terumo, Inc.Enrolling by invitationIntracranial AneurysmsUnited States
-
Zhuhai Tonbridge Medical Tech. Co., Ltd.CompletedIntracranial AneurysmsChina
-
Mercy Health OhioStryker NeurovascularUnknown
-
Penumbra Inc.CompletedIntracranial AneurysmsFrance
-
Dr. med. Julius DenglerCharite University, Berlin, GermanyUnknownIntracranial AneurysmsAustria, Finland, France, Germany, Italy, Japan, Netherlands, Russian Federation, Switzerland
-
Stryker NeurovascularCompletedIntracranial AneurysmsUnited States, Germany, Canada, Spain, Norway, Australia, China, France, Mexico, Turkey, United Kingdom
Clinical Trials on FRED
-
Microvention-Terumo, Inc.ClinactCompletedIntracranial AneurysmUnited Kingdom
-
Microvention-Terumo, Inc.Active, not recruiting
-
Microvention-Terumo, Inc.Completed
-
Microvention-Terumo, Inc.CompletedIntracranial Aneurysms
-
Microvention-Terumo, Inc.CompletedIntracranial AneurysmsUnited States, Japan
-
Northumbria UniversityEuropean Space Agency; Aalborg University; The University of Queensland; International...UnknownLow Back Pain, Mechanical
-
Microvention-Terumo, Inc.RecruitingIntracranial AneurysmUnited States
-
Begoña Garcia ZapirainProvincial Council of Bizkaia; Basque GovernmentCompleted